Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5685359 | American Journal of Kidney Diseases | 2017 | 9 Pages |
Abstract
Patients initiating HD therapy in facilities almost exclusively using iron sucrose versus ferric gluconate had similar longer-term outcomes. However, there was a small decrease in infectious hospitalizations and deaths in patients dialyzing in facilities predominantly using iron sucrose. This difference may be due to residual confounding, random chance, or a causal effect.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Wolfgang C. MD, MPH, ScD, Benjamin A. PhD, Aya A. MPH, Victoria Y. MSc, Medha MD, Sreedhar MD, MPH, Tara I. MD, MSc, M. Alan PhD, Steven MD,